Woods (20) showed that sulfanilamide owed its bacteriostatic activity to its competition with p-aminobenzoic acid (PABA). Later, Lascelles and Woods (10) demonstrated that sulfanilamide blocked the sequence of reactions leading to the biosynthesis of folic acid. Since that time, the inhibition of in vivo folic acid biosynthesis by sulfonamides has been established (21) as well as the enzymatic sequence involved in folic acid biosynthesis by cell-free preparations derived from both bacteria and plants (14) .
increased. Temperature studies have revealed differences in the dihydropteroate synthetase from N. meningitidis and N. gonorrhoeae. A direct relationship was observed between the minimal inhibitory concentration of sulfanilamide determined in vitro and the ratio of KJK,. This ratio may be a molecular explanation of sulfanilamide resistance for both N. meningitidis and N. gonorrhoeae.
Woods (20) showed that sulfanilamide owed its bacteriostatic activity to its competition with p-aminobenzoic acid (PABA). Later, Lascelles and Woods (10) demonstrated that sulfanilamide blocked the sequence of reactions leading to the biosynthesis of folic acid. Since that time, the inhibition of in vivo folic acid biosynthesis by sulfonamides has been established (21) as well as the enzymatic sequence involved in folic acid biosynthesis by cell-free preparations derived from both bacteria and plants (14) .
The biosynthetic pathway for dihydropteroate proceeds via the two reactions:
pneumoniae was attributable to alterations in the PABA and sulfonamide binding groups of one enzyme (dihydropteroate synthetase). They were able to partially purify this enzyme and indicated that both the sulfa resistance and susceptibility observed in intact cells was correlated with dihydropteroate synthetase activity in cell-free extracts. Since then several laboratories (1, 8, 16 ; G. M. Brown, Fed. Proc. 18:19) have attempted to defme the nature of this alteration.
The present study evaluates alterations in the enzyme dihydropteroic acid synthetase, which may explain variations in sulfonamide sensitiv-2-amino-4-hydroxy-6-hydroxymethyldihydropteridine + adenosine triphosphate -* 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine -pyrophosphate (PP) + adenosine monophosphate
2-amino-4-hydroxy-6-hydroxymethyldihydropteridine !-PP + PABA -_ dihydropteroate + PP (2) Recently, Ortiz (15) OWganisms and preparation of cell-ree extracts.
The properties of the organisms used in this study are shown in Table 1 . Agar-grown cultures of N. meningitidis were harvested after 18 to 24 h of growth at 37 C on Mueller-Hinton agar (Difco) plates. Cells were removed by gentle scraping, suspended in a minimal volume (usually 5 ml for five to six plates) of 0.1 M phosphate-buffered saline (pH 7.2), and ruptured by use of a Ribi cell fractionator (Ivan Sorvall Inc. Norwalk, Conn.). Extracts were centrifuged (45,000 x g for 30 min) to remove particulate material. Agar-grown cultures of N. gonorrhoeae were harvested after 18 to 24 h growth on GC agar (Difco) plates at 37 C in a CO, incubator containing 5% CO,.
Cells were removed by gentle scraping, suspended in a minimal volume of 0.1 M phosphate-buffered saline (pH 7.2), and disrupted in a cell homogenizer (Braun, model MSK). The resulting suspension was centrifuged at low speed (12 ,000 x g for 15 min) to remove the glass beads followed by centrifugation at high speed (45,000 x g for 30 min) to remove the remaining particulate material. All cell-free extracts were stored at -30 C until assayed.
Treatment of cell-f extracts. All extracts contained small amounts of folic acid, or some other substance(s), which stimulated the growth of Streptococcus faecium (ATCC 8043). Therefore, it became necessary to subject the extracts to ammonium sulfate fractionation and extensive dialysis to minimize the effect of this contaminant. Extracts were brought to 30% saturation by the slow addition of solid ammonium sulfate and gently stirred for 60 min at 4 C. If no precipitate was observed at this point, the solution was brought to 65% saturation and stirred for an additional hour. After centrifugation, the precipitate was dissolved in a minimal volume of 0.05 M tris(hydroxymethyb)aminomethane (Tris)-hydrochloride buffer (pH 8.1 to 8.2) and dialyzed against 9 liters of this buffer for a period of 9 h.
Preparation and reduction of substrates. Hydroxymethylpteridine was prepared by the method of Forrest and Walker (4) and purified by repeated recrystallization from water. The purity of the recrystallized product was demonstrated by paper chromatography (14) . The absorption spectra and Rt values were identical with those of authentic samples (14) . Hydroxymethyldihydropteridine-PP was chemically prepared (17) and purified on a Dowex-1 anion exchange column as suggested in a personal communication from T. Shiota (Department of Microbiology, University of Alabama). Immediately before use the above compound, as well as pteroic acid, was reduced to the dihydro-form with sodium hydrosulfite by the method of Futterman (5). Enzyme assay. Dihydropteroate synthetase was assayed by a direct assay system. The reaction mixture consisted of: 50 mM Tris-hydrochloride buffer (pH 8.1 to 8.2); 0.025 mM hydroxymethyldihydropteridine-PP; 1.8 to 15 mM PABA; and 24 mM 2-mercaptoethanol in a total volume of 6.42 ml. The complete enzyme reactions were carried out under anaerobic conditions (argon gas). The constituents were mixed well, and the reaction was started by the addition of partially purified extract. Reaction mixtures were incubated at 25 C and, at specific intervals, 1-ml samples were transferred to tubes containing 0.1 ml of potassium ascorbate solution (3 mg of potassium ascorbate per ml) and heated in a boiling water bath for 4 min. The amount of product formed was assayed for folate activity by microbiological assay.
Microbiological assay. The product of enzyme activity, dihydropteroic acid, was measured by the growth response of S. faecium (ATCC 8043). The assay organism was grown in the medium of Flynn et al. (3) (Fig. 1) are summarized in Table 2 .
The value for K. was essentially the same for all three strains. The V.ax of the enzyme reaction decreased as the sulfanilamide resistance of the strain increased. The competitive nature of the inhibition of dihydropteroate synthetase by sulfanilamide is shown in Fig. 1 Figure 2 demonstrates the competitive nature of the inhibition of dihydropteroate synthetase by sulfanilamide; the increase in the K, values (Table 3 ) indicated a decreased affmity for sulfanilamide as the resistance of the strain to the drug increased.
The effect of assay temperature on the activities of dihydropteroate synthetase from N. meningitidis and N. gonorrhoeae is shown in Table 4 . Maximal activity was observed at 37 C for all three strains of N. meningitidis; the temperature range broadened as the resistance of the strain to sulfanilamide increased. No activity was observed at 55 C. In contrast, appreciable activity was observed at 55 C in extracts from all three strains of N. gonorrhoeae. Of particular interest was the observation that the optimal temperature, as well as the heat stability of the enzyme, increased as the resistance to sulfanilamide increased.
The effect of temperature on dihydropteroate Table 2 . conclusion. Kinetic studies showed that dihydropteroate synthetase from both species had a reduced affinity for sulfanilamide which paralleled the increased resistance of the organism to the drug. To the best of our knowledge, this is the first report confirming that the mechanism of sulfanilamide resistance in clinical isolates is the same as in genetically manipulated orga-
nisms.
Temperature stability studies demonstrated differences in the enzyme in extracts of N. meningitidis and N. gonorrhoeae. The heat stability of dihydropteroate synthetase in extracts of either organism increased with increasing resistance. However, although the optimal temperature for activity was the same for all strains of N. meningitidis, it increased as the sulfanilamide resistance of the strain of N. gonorrhoeae increased. These differences substantiate in part the work of Catlin (2) , who showed that sulfanilamide resistance in N. meningitidis and N. gonorrhoeae resulted from a species-specific genetic alteration. VOL. 5, 1974 meningitidis and N. gonorrhoeae used in this study (Table 6 ). This ratio may be a molecular explanation of the MIC of sulfanilamide for these particular organisms. Studies are in progress to test the application of this ratio with other strains of these pathogens and with other sulfa drugs as McCullough and Maren (12) and Thijssen (18) have done with Escherichia coli.
